Rifamycin Sodium Patent Expiration
Rifamycin Sodium is Used for treating travelers' diarrhea caused by non-invasive strains of Escherichia coli in adults. It was first introduced by Redhill Biopharma Inc
Rifamycin Sodium Patents
Given below is the list of patents protecting Rifamycin Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aemcolo | US8263120 | Oral antimicrobial pharmaceutical compositions | May 03, 2025 | Redhill |
| Aemcolo | US8486446 | Oral antimicrobial pharmaceutical compositions | May 03, 2025 | Redhill |
| Aemcolo | US8529945 | Oral antimicrobial pharmaceutical compositions | May 03, 2025 | Redhill |
| Aemcolo | US8741948 | Oral antimicrobial pharmaceutical compositions | May 03, 2025 | Redhill |
Rifamycin Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List